Cargando…
Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
Background: In the metastatic setting, cancer patients may not benefit from standard care regimes and their diseases undergo drug resistance due to tumour cell heterogeneity and genomic landscape complexity. In recent years, there have been several attempts to personalise the diagnostic-therapeutic...
Autores principales: | Ballatore, Zelmira, Bozzi, Francesco, Cardea, Sara, Savino, Francesco Domenico, Migliore, Antonella, Tarantino, Valentina, Chiodi, Natalia, Ambrosini, Elisa, Bianchi, Francesca, Goteri, Gaia, Filosa, Alessandra, Barbisan, Francesca, Bartoli, Elisa, Papa, Roberto, Berardi, Rossana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607087/ https://www.ncbi.nlm.nih.gov/pubmed/37892804 http://dx.doi.org/10.3390/jcm12206666 |
Ejemplares similares
-
A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2023) -
Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023) -
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020) -
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015) -
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)